Animal NDC 58198-0327-1 Compudose
Estradiol
Animal Product Information
Field Name | Field Value |
---|---|
Animal NDC Code | 58198-0327-1 |
Proprietary Name | Compudose What is the Proprietary Name? The proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes. |
Non-Proprietary Name | Estradiol What is the Non-Proprietary Name? The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product. |
Labeler Name | Elanco Us Inc. |
Product Type | Otc Animal Drug |
Usage Information |
|
Active Ingredient(s) |
|
Marketing Category | NADA - NEW ANIMAL DRUG APPLICATION What is the Marketing Category? Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
FDA Application Number | NADA118123 What is the FDA Application Number? This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null. |
Compudose Animal Product Labeling Information
The product labeling information includes all published material associated to a drug. Product labeling documents include information like generic names, active ingredients, ingredient strength dosage, routes of administration, appearance, usage, warnings, inactive ingredients, etc.
Table of Contents
Other
Elanco™
AH0948
Compudose™
(estradiol extended-release implants)
Each extended-release implant consists of 25.7 mg estradiol
Description:
Each Compudose (estradiol extended-release implant) silicone rubber implant contains 25.7 mg estradiol and is coated with sodium bicarbonate.
For subcutaneous ear implantation only.
Indications For Use:
• For increased rate of weight gain for up to 200 days in beef steer calves 2 months of age and older.• For increased rate of weight gain for up to 200 days in growing beef steers on pasture (stocker, feeder, and slaughter).• For increased rate of weight gain and improved feed efficiency for up to 200 days in growing beef steers and heifers fed in confinement for slaughter.• This implant is not approved for repeated implantation (reimplantation) with this or any other cattle ear implant within each separate production phase:• Beef steer calves 2 months of age and older• Growing beef steers on pasture (stocker, feeder, and slaughter)• Growing beef steers and heifers fed in confinement for slaughter
Safety and effectiveness following reimplantation have not been evaluated.
Do not use in beef calves less than 2 months of age, dairy calves, and veal calves because effectiveness and safety have not been established.
Do not use in animals intended for subsequent breeding or in dairy cows.
Directions:
Insert one implant under the skin of the ear as directed in the detailed "DIRECTIONS FOR IMPLANTATION" below.
WITHDRAWAL PERIODS AND RESIDUE WARNINGS No withdrawal period is required when used according to labeling. Do not use in beef calves less than 2 months of age, dairy calves, and veal calves. A withdrawal period has not been established for this product in pre-ruminating calves. Do not use in dairy cows or in animals intended for subsequent breeding. Use in these cattle may cause drug residues in milk and/or in calves born to these cows. Implant pellets subcutaneously in ear only. Any other location is a violation of Federal law. Do not attempt salvage of implanted site for human or animal food. |
User Safety Warnings:
Not for use in humans.
Keep out of reach of children.
Animal Safety Warnings:
Increased sexual activity (bulling, riding and excitability) has been reported in animals implanted with Compudose. Implanted animals should be observed for such signs particularly during the first few days after implanting and animals being excessively ridden (bullers) should be removed to prevent physical injury.
Vaginal and rectal prolapse have been reported in heifers implanted with Compudose.
Udder development, swollen or enlarged vulva and high tailheads may be observed in implanted heifers.
Directions For Implantation:
A Compudose (estradiol extended-release implant) or Encore (estradiol extended-release implant) Implanter must be used to implant cattle.
Insert one implant under the skin of the ear.
1. Confine animal in a squeeze chute.2. To reduce the possibility of infection and resulting implant loss, hygienic and antiseptic procedures should be followed during implantation. The ear should be clean and dry. The skin should be cleansed with a suitable antiseptic soap and dried prior to implanting. This is particularly important if the ears are contaminated with urine or feces.3. To load the Compudose/Encore™ Implanter remove the cartridge from the package, release the latch on the magazine, open and insert the cartridge. (Figure 1)
Close the magazine and latch. Advance the cartridge to the next implant by inserting the thumb into the magazine opening and turning the cartridge to the next stop.
Use a sharp needle. The needle should be cleaned and sterilized between each injection by wiping the exterior with a sponge, cloth, or gauze saturated with an appropriate disinfectant.Figure 1 4. The implant should be deposited under the skin on the back side of the middle third of the ear. It should be placed between the skin and cartilage, avoiding major blood vessels.
Grasping the tip of the ear with one hand and the implanter in the other, penetrate the skin in the outer third of the ear. (see Figure 2)5. Upon penetration, the needle should be fully inserted (Figure 3) between the skin and cartilage, avoiding major blood vessels. Full insertion of the needle is important to maximize implant retention.6. Pull the needle back as the implant is being deposited by squeezing the lever on the implanter grip. Figure 4 shows the implant in proper position in the middle third of the ear where the skin is tight.7. Periodically remove the needle from the device and wash it in water. Before reusing, the needle should be disinfected and allowed to dry after shaking vigorously to remove excess water or disinfectant.Proper Position
A. Fully insert the needle.B. Deposit the implant in the middle third of the ear where the skin is tight.C. Do not deposit the implant where the skin is loose in the third of the ear closest to the head.
To maximize implant retention:
The needle has been scientifically designed to maximize retention. When it becomes dull, use a new needle. If the needle is resharpened, sharpen only the point.
Failure to follow antiseptic implanting procedures, particularly when the ears are contaminated with fecal material, may result in infection and excessive implant loss. Implanting cattle during wet weather may increase infection and implant loss.
Carefully check the ears for implant loss approximately 4 weeks after implantation. If loss occurs, reimplant using recommended procedures.
How Supplied:
Compudose Implants are supplied in cartridges of 20 implants each.
Storage Conditions
Store at 15 to 25°C (59-77°F). Do not refrigerate or freeze.
Approved by FDA under NADA # 118-123
Manufactured by a non-sterilizing process.
RESTRICTED DRUG (CALIFORNIA) – USE ONLY AS DIRECTED
Compudose, Encore, Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates.
© 2023 Elanco or its affiliates
Distributed by Elanco US, Inc.
Greenfield, IN 46140, USA
Product of Germany
To report side effects, for technical assistance or to obtain a copy of the Safety Data Sheet (SDS), contact Elanco US Inc., at 1-888-545-5973. For additional information about reporting side effects for animal drugs, contact FDA at 1-888-FDA-VETS or http://www.fda.gov/reportanimalae.
May 2023 PA104038X
Principal Display Panel - Compudose Carton Label
Elanco™
AH0948
Compudose™
™
(estradiol extended-release implants)
Each extended-release implant consists of 25.7 mg estradiol
Net contents:
5 CARTRIDGES
Each Cartridge
contains 20 implants
(100 Implants total)
Principal Display Panel - Compudose Cartridge Label
AH0948
Elanco™
Compudose™
™
(estradiol extended-release implants)
Each implant consists of 25.7 mg estradiol
20 IMPLANTS
* The information on this page is for an ANIMAL PRODUCT, please review the complete disclaimer below.